Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 2
Submit an article Journal homepage
514
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute – Waldenström Macroglobulinemia 1

Kasyapa S. ChittaDepartment of Hematology and Oncology;Cancer Basic Science
,
Aneel PaulusDepartment of Medicine
,
Sikander AilawadhiDivision of Hematology, University of Southern California, Los Angeles, CA, USA
,
Barbara A. FosterDepartment of Pharmacology and Therapeutics
,
Michael T. MoserDepartment of Pharmacology and Therapeutics
,
Petr StarostikDepartment of Pathology
,
Aisha MasoodBone Marrow Transplant Unit, The Tisch Cancer Institute, New York, NY, USA
,
Taimur SherDepartment of Hematology and Oncology
,
Kena C. MillerDepartment of Hematology and Oncology;Department of Medicine
,
Dan M. IancuDepartment of Pathology
,
Jeffrey ConroyCancer Genetics, Roswell Park Cancer Institute, Buffalo, NY, USA
,
Norma J. NowakCancer Genetics, Roswell Park Cancer Institute, Buffalo, NY, USA;Department of Biochemistry and Center of Excellence in Bioinformatics and Life Sciences, University at Buffalo, NY and Bone Marrow Transplant Unit, The Tisch Cancer Institute, New York, NY, USA
,
Sheila N. SaitDepartment of Pathology
,
David A. PersonettCancer Basic Science
,
Morton ColemanDepartment of Medicine, Weill Cornell Medical College, Cornell, NY, USA
,
Richard R. FurmanDepartment of Medicine, Weill Cornell Medical College, Cornell, NY, USA
,
Peter MartinDepartment of Medicine, Weill Cornell Medical College, Cornell, NY, USA
,
Stephen M. AnsellDivision of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA
,
Kelvin LeeDepartment of Medicine;Department of Immunology
&
Asher A. Chanan-KhanDepartment of Hematology and Oncology;Cancer Basic Science;Clinical Studies Unit, Mayo Clinic, Jacksonville, FL, USACorrespondence[email protected]
 show all
Pages 387-396 | Received 25 May 2012, Accepted 15 Jul 2012, Published online: 27 Aug 2012

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Vijay Sagar Madamsetty, Aneel Paulus, Sharoon Akhtar, Alak Manna, Harikrishna Reddy Rachamalla, RajKumar Banerjee, Debabrata Mukhopadhyay & Asher Chanan-Khan. (2020) Novel tumor-targeted liposomes comprised of an MDM2 antagonist plus proteasome inhibitor display anti-tumor activity in a xenograft model of bortezomib-resistant Waldenstrom macroglobulinemia. Leukemia & Lymphoma 61:10, pages 2399-2408.
Read now

Articles from other publishers (19)

Mona Karbalivand, Luciana L. Almada, Stephen M. Ansell, Martin E. Fernandez-Zapico & Sherine F. Elsawa. (2022) MLL1 inhibition reduces IgM levels in Waldenström macroglobulinemia. Leukemia Research 116, pages 106841.
Crossref
Stephan J Matissek, Weiguo Han, Mona Karbalivand, Mohamed Sayed, Brendan M Reilly, Shayna Mallat, Shimaa M Ghazal, Manit Munshi, Guang Yang, Steven P Treon, Sarah R Walker & Sherine F Elsawa. (2021) Epigenetic targeting of Waldenström macroglobulinemia cells with BET inhibitors synergizes with BCL2 or histone deacetylase inhibition. Epigenomics 13:2, pages 129-144.
Crossref
Weiguo Han, Stephan J. Matissek, David A. Jackson, Brandon Sklavanitis & Sherine F. Elsawa. (2019) Targeting IL-6 receptor reduces IgM levels and tumor growth in Waldenström macroglobulinemia. Oncotarget 10:36, pages 3400-3407.
Crossref
Aneel Paulus, Alak Manna, Sharoon Akhtar, Shumail M. Paulus, Mayank Sharma, Marie V. Coignet, Liuyan Jiang, Vivek Roy, Thomas E. Witzig, Stephen M. Ansell, John Allan, Richard Furman, Sonikpreet Aulakh, Rami Manochakian, Sikander Ailawadhi, Asher A. Chanan-Khan & Taimur Sher. (2018) Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells. British Journal of Haematology 183:2, pages 196-211.
Crossref
Naoki Wada, Satoshi Nojima, Shin-ichiro Tahara, Kenji Ohshima, Masako Kurashige, Keisuke Kawasaki, Mitsuyo Tone, Shinya Kusumoto, Jun-ichiro Ikeda & Eiichi Morii. (2018) Effect of glutamine on lymphoplasmacytic lymphoma, especially on the viewpoint of the differentiation into vulnerable subpopulation. Pathology - Research and Practice 214:10, pages 1667-1674.
Crossref
Jason E. Conage‐Pough & Lawrence H. Boise. (2018) Phosphorylation alters Bim‐mediated Mcl‐1 stabilization and priming. The FEBS Journal 285:14, pages 2626-2640.
Crossref
Naoki Wada, Jun-ichiro Ikeda, Hiromasa Tanaka, Hajime Sakakita, Masaru Hori, Yuzuru Ikehara & Eiichi Morii. (2017) Effect of plasma-activated medium on the decrease of tumorigenic population in lymphoma. Pathology - Research and Practice 213:7, pages 773-777.
Crossref
Weiguo Han, David A. Jackson, Stephan J. Matissek, Jason A. Misurelli, Matthew S. Neil, Brandon Sklavanitis, Nansalmaa Amarsaikhan & Sherine F. Elsawa. (2017) Novel Molecular Mechanism of Regulation of CD40 Ligand by the Transcription Factor GLI2. The Journal of Immunology 198:11, pages 4481-4489.
Crossref
Steven J. Wang, Saurabh Asthana, Annemieke van Zante, Chase M. Heaton, Janyaporn Phuchareon, Leighton Stein, Saito Higuchi, Tomoya Kishimoto, Charles Y. Chiu, Adam B. Olshen, Frank McCormick & Osamu Tetsu. (2017) Establishment and characterization of an oral tongue squamous cell carcinoma cell line from a never-smoking patient. Oral Oncology 69, pages 1-10.
Crossref
V S Tompkins, R Sompallae, T R Rosean, S Walsh, M Acevedo, A L Kovalchuk, S-S Han, X Jing, C Holman, J E Rehg, S Herms, J S Sunderland, H C Morse & S Janz. (2016) Transgenic mouse model of IgM+ lymphoproliferative disease mimicking Waldenström macroglobulinemia. Blood Cancer Journal 6:11, pages e488-e488.
Crossref
A Paulus, S Akhtar, T R Caulfield, K Samuel, H Yousaf, Y Bashir, S M Paulus, D Tran, R Hudec, D Cogen, J Jiang, B Edenfield, A Novak, S M Ansell, T Witzig, P Martin, M Coleman, V Roy, S Ailawadhi, K Chitta, S Linder & A Chanan-Khan. (2016) Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells. Blood Cancer Journal 6:11, pages e492-e492.
Crossref
Aneel Paulus, Sikander Ailawadhi & Asher Chanan-Khan. (2016) Novel therapeutic targets in Waldenstrom macroglobulinemia. Best Practice & Research Clinical Haematology 29:2, pages 216-228.
Crossref
Sikander Ailawadhi, Aneel Paulus & Asher Chanan-Khan. (2016) Preclinical models of Waldenstr?m's macroglobulinemia and drug resistance. Best Practice & Research Clinical Haematology 29:2, pages 169-178.
Crossref
B T Gaudette, B Dwivedi, K S Chitta, S Poulain, D Powell, P Vertino, X Leleu, S Lonial, A A Chanan-Khan, J Kowalski & L H Boise. (2015) Low expression of pro-apoptotic Bcl-2 family proteins sets the apoptotic threshold in Waldenström macroglobulinemia. Oncogene 35:4, pages 479-490.
Crossref
. 2016. Diagnostic Pathology: Molecular Oncology. Diagnostic Pathology: Molecular Oncology 6-40 6-45 .
David A. Jackson, Timothy D. Smith, Nansalmaa Amarsaikhan, Weiguo Han, Matthew S. Neil, Shannon K. Boi, Anne M. Vrabel, Ezequiel J. Tolosa, Luciana L. Almada, Martin E. Fernandez-Zapico & Sherine F. Elsawa. (2015) Modulation of the IL-6 Receptor α Underlies GLI2-Mediated Regulation of Ig Secretion in Waldenström Macroglobulinemia Cells. The Journal of Immunology 195:6, pages 2908-2916.
Crossref
Aneel Paulus, Kasyapa S. Chitta, Paul K. Wallace, Pooja P. Advani, Sharoon Akhtar, Maja Kuranz-Blake, Sikander Ailawadhi & Asher A. Chanan-Khan. (2015) Immunophenotyping of Waldenströms Macroglobulinemia Cell Lines Reveals Distinct Patterns of Surface Antigen Expression: Potential Biological and Therapeutic Implications. PLOS ONE 10:4, pages e0122338.
Crossref
K Chitta, A Paulus, T R Caulfield, S Akhtar, M-KK Blake, S Ailawadhi, J Knight, M G Heckman, A Pinkerton & A Chanan-Khan. (2014) Nimbolide targets BCL2 and induces apoptosis in preclinical models of Waldenströms macroglobulinemia. Blood Cancer Journal 4:11, pages e260-e260.
Crossref
Siegfried Janz. (2013) Waldenström Macroglobulinemia: Clinical and Immunological Aspects, Natural History, Cell of Origin, and Emerging Mouse Models. ISRN Hematology 2013, pages 1-25.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.